… Recombinant trivalent influenza vaccine (RIV3) was initially licensed in 2013 … study
evaluated the safety of RIV3 compared with trivalent standard-dose, inactivated influenza vaccine (…

… of inactivated influenza vaccines in children younger than 2 years. We aimed to establish
the … of trivalent inactivated influenza vaccine against laboratory-confirmed influenza A and B …

… We assumed a true VE of 70%, based on the demonstration of a vaccine efficacy of 66%
in year 1 of a placebo-controlled randomized study of trivalent inactivated influenza vaccine …

… This study shows that influenza vaccination may have a clinical benefit in allo-HSCT
recipients with virologically-confirmed RVI, in terms of a lower influenza RVI prevalence, slower …

… Because all the investigations in this study are “observational,” the people who had been
vaccinated might share another unknown characteristic that is actually responsible for …

… influenza vaccination in observational studies, which was corroborated by a recent observational
study by … may be protected in schools with vaccination rates approaching 50% [32]. …

… Recombinant influenza vaccine (RIV) has been in use in US adults since 2013. This
study evaluated the safety of quadrivalent recombinant influenza vaccine (RIV4, Flublok® …

… non-randomised observational study has shown that influenza vaccine … vaccine is used.
Healthcare workers in Singapore should be encouraged to go for annual influenza vaccination …

… Although trivalent inactivated influenza … the study [7], while subsequent observational studies
of vaccine effectiveness have been challenged on methodological grounds, and the vaccine…

… We report the results of a prospective observational study of the humoral immunogenicity
of the inactivated influenza vaccine (IIV) among CAR-T-cell therapy recipients vaccinated …